Peptide therapy TikTok claims: what the science actually supports

What's this video probably claiming?

Accounts in the peptide space on TikTok typically run a familiar playbook: stack BPC-157 with TB-500 for accelerated injury healing, use CJC-1295 with ipamorelin to boost growth hormone and torch body fat, and throw in GHK-Cu for skin and cellular repair. MK-677, despite not being a true peptide, gets lumped in as a "safer" GH secretagogue. Creators in this category often frame these compounds as the thing your sports medicine doctor won't tell you about, drawing heavily on anecdote and before/after physique changes. Without a transcript we can't pin specific claims to this creator, but the category pattern is consistent enough to fact-check the underlying assertions directly. The general pitch is: these compounds work like pharmaceutical-grade therapies, carry minimal risk, and are accessible to anyone willing to do a little research.

What does the science actually show?

The honest answer is: it depends heavily on which peptide you're talking about, and almost none of the human evidence is strong. BPC-157 has a legitimate preclinical record. A 2016 review by Sikiric et al. in Current Pharmaceutical Design documented consistent pro-angiogenic and tendon-healing effects in rodent models, but zero completed randomized controlled trials in humans exist as of 2024. TB-500 (thymosin beta-4) is similar: animal wound-healing data is real, but the one Phase II human trial (RegeneRx, 2012) in cardiac patients showed modest effects and was never followed up for musculoskeletal use. CJC-1295 does meaningfully raise IGF-1. A 2006 study by Teichman et al. in the Journal of Clinical Endocrinology and Metabolism showed a 2-fold to 10-fold increase in GH pulse amplitude at doses of 30-60 mcg/kg, with IGF-1 elevation sustained for 6 days. That pharmacology is real. Whether it translates to the body composition outcomes being claimed is a different question entirely.

Where does the social media noise diverge from clinical reality?

Several places. First, the "no side effects" framing is false. MK-677 at 25 mg daily, studied by Murphy et al. in 1998 in the Journal of Clinical Endocrinology and Metabolism, increased GH and IGF-1 but also significantly raised fasting glucose and caused fluid retention. It worsened insulin resistance in elderly subjects. That doesn't make it unusable, but it makes the "totally safe" claim misleading. Second, the stacking logic that circulates online has no clinical trial backing at all. Combining a GHRH analog like CJC-1295 with a ghrelin mimetic like ipamorelin is mechanistically plausible, but no peer-reviewed trial has tested that combination's safety profile in non-deficient adults. Third, GHK-Cu is being marketed as a systemic anti-aging peptide based largely on in vitro data. Pickart and Margolina's 2018 paper in Biomedicines documents copper peptide effects on gene expression in cell cultures, which is interesting but nowhere near clinical proof of the anti-aging effects being implied.

What should you actually know?

Peptides are not a monolith. Some have plausible mechanisms and early human data worth discussing with a clinician. Others are being sold on vibes and rodent studies. The regulatory picture matters: most peptides discussed in this category are not FDA-approved for the indications being claimed. The FDA removed BPC-157 and several other peptides from the bulk compounding list in 2023, citing insufficient safety data, which is a meaningful signal that should be mentioned in any honest review. Semax and selank, popular in nootropic circles, have some Russian clinical literature behind them but essentially no peer-reviewed Western trial data. Anyone considering these compounds should be working with a licensed prescriber who can order baseline labs, monitor IGF-1 and fasting glucose, and actually assess risk. A TikTok creator, regardless of how credible they sound, cannot do that for you.